New cancer clinical trial: A Phase II Randomized Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy as Maintenance Therapy in Patients With PIK3CA Mutated Advanced Breast Cancer

Published on: December 29, 2017 at 10:00AM
Condition:   Breast Cancer, PI3K, Alpelisib
Interventions:   Drug: Alpelisib;   Drug: Chemotherapy
Sponsor:   UNICANCER
Not yet recruiting
http://ift.tt/2CeuMB2